Literature DB >> 11708925

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.

M J Meyers1, J Sun, K E Carlson, G A Marriner, B S Katzenellenbogen, J A Katzenellenbogen.   

Abstract

Through an effort to develop novel ligands that have subtype selectivity for the estrogen receptors alpha (ERalpha) and beta (ERbeta), we have found that 2,3-bis(4-hydroxyphenyl)propionitrile (DPN) acts as an agonist on both ER subtypes, but has a 70-fold higher relative binding affinity and 170-fold higher relative potency in transcription assays with ERbeta than with ERalpha. To investigate the ERbeta affinity- and potency-selective character of this DPN further, we prepared a series of DPN analogues in which both the ligand core and the aromatic rings were modified by the repositioning of phenolic hydroxy groups and by the addition of alkyl substituents and nitrile groups. We also prepared other series of DPN analogues in which the nitrile functionality was replaced with acetylene groups or polar functions, to mimic the linear geometry or polarity of the nitrile, respectively. To varying degrees, all of the analogues show preferential binding affinity for ERbeta (i.e., they are ERbeta affinity-selective), and many, but not all of them, are also more potent in activating transcription through ERbeta than through ERalpha (i.e., they are ERbeta potency-selective). meso-2,3-Bis(4-hydroxyphenyl)succinonitrile and dl-2,3-bis(4-hydroxyphenyl)succinonitrile are among the highest ERbeta affinity-selective ligands, and they have an ERbeta potency selectivity that is equivalent to that of DPN. The acetylene analogues have higher binding affinities but somewhat lower selectivities than their nitrile counterparts. The polar analogues have lower affinities, and only the fluorinated polar analogues have substantial affinity selectivities. This study suggests that, in this series of ligands, the nitrile functionality is critical to ERbeta selectivity because it provides the optimal combination of linear geometry and polarity. Furthermore, the addition of a second nitrile group beta to the nitrile in DPN or the addition of a methyl substitutent at an ortho position on the beta-aromatic ring increases the affinity and selectivity of these compounds for ERbeta. These ERbeta-selective compounds may prove to be valuable tools in understanding the differences in structure and biological function of ERalpha and ERbeta.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708925     DOI: 10.1021/jm010254a

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  223 in total

1.  Acute effects of oestrogen receptor subtype-specific agonists on vascular contractility.

Authors:  Sandra Montgomery; Linda Shaw; Nick Pantelides; Michael Taggart; Clare Austin
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 2.  Estrogen receptor-α and estrogen receptor-β in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow.

Authors:  Mayra B Pastore; Sheikh O Jobe; Jayanth Ramadoss; Ronald R Magness
Journal:  Semin Reprod Med       Date:  2012-01-23       Impact factor: 1.303

3.  Rapid detection of subtype-selective nuclear hormone receptor binding with bacterial genetic selection.

Authors:  Georgios Skretas; David W Wood
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

Review 4.  Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.

Authors:  John H Morrison; Roberta D Brinton; Peter J Schmidt; Andrea C Gore
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

5.  Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity.

Authors:  Emanuela Teveroni; Marsha Pellegrino; Sabrina Sacconi; Patrizia Calandra; Isabella Cascino; Stefano Farioli-Vecchioli; Angela Puma; Matteo Garibaldi; Roberta Morosetti; Giorgio Tasca; Enzo Ricci; Carlo Pietro Trevisan; Giuliana Galluzzi; Alfredo Pontecorvi; Marco Crescenzi; Giancarlo Deidda; Fabiola Moretti
Journal:  J Clin Invest       Date:  2017-03-06       Impact factor: 14.808

6.  The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin.

Authors:  Joëlle Rüegg; Elin Swedenborg; David Wahlström; Aurelie Escande; Patrick Balaguer; Katarina Pettersson; Ingemar Pongratz
Journal:  Mol Endocrinol       Date:  2007-11-08

7.  Both estrogen receptor α and β stimulate pituitary GH gene expression.

Authors:  Dimiter Avtanski; Horacio J Novaira; Sheng Wu; Christopher J Romero; Rhonda Kineman; Raul M Luque; Fredric Wondisford; Sally Radovick
Journal:  Mol Endocrinol       Date:  2013-01-01

8.  The memory-enhancing effects of hippocampal estrogen receptor activation involve metabotropic glutamate receptor signaling.

Authors:  Marissa I Boulware; John D Heisler; Karyn M Frick
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

9.  Estradiol after cardiac arrest and cardiopulmonary resuscitation is neuroprotective and mediated through estrogen receptor-beta.

Authors:  Ruediger R Noppens; Julia Kofler; Marjorie R Grafe; Patricia D Hurn; Richard J Traystman
Journal:  J Cereb Blood Flow Metab       Date:  2008-10-29       Impact factor: 6.200

10.  Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

Authors:  Carolyn D DuSell; Erik R Nelson; Bryan M Wittmann; Jackie A Fretz; Dmitri Kazmin; Russell S Thomas; J Wesley Pike; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.